ARCHIVES

Risks Of Long-Term HRT Outweigh Benefits, WHI Finds

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

Ethics Commission to Meet In L.A.

September 4, 1981

Immunotherapy Demonstrates Disease Control in Phase II Study

September 28, 2012

A. Lindo Patterson: Pioneer and Mentor

October 26, 2021

AACI Resolution Asks Congress To Support 1991 Bypass Budget

July 13, 1990

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010